Newsroom

Sorted by: Latest

-

SAMSE : MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L’ASSEMBLEE GENERALE MIXTE DES ACTIONNAIRES DU 21 MAI 2026

GRENOBLE--(BUSINESS WIRE)--Regulatory News: SAMSE (Paris:SAMS) informe ses actionnaires qu’une Assemblée Générale Mixte se tiendra le Jeudi 21 mai 2026 à 14 heures au siège social de la société. L’avis de réunion valant avis de convocation a été publié au Bulletin des Annonces Légales et Obligatoires (BALO) le 15 avril 2026. L’avis de convocation, qui contient notamment l’ordre du jour de cette Assemblée et les projets de résolutions qui lui seront soumis ainsi que les modalités de participatio...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 28.04.2026 GFEB.LN IE000X8M8M80 700,002.00 USD 26,835,460.73 38.336  ...
-

Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada

HYDERABAD, India & MISSISSAUGA, Ontario--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic Semaglutide Injection....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 28.04.2026 KNG.LN IE000SNMGYT5 900,002.00 USD 18,303,339.89 20.337  ...
-

Visa lanza Visa Agentic Ready, un programa para impulsar el comercio agéntico en América Latina y el Caribe

MIAMI--(BUSINESS WIRE)--Visa (NYSE: V) anunció hoy el lanzamiento de Visa Agentic Ready en América Latina y el Caribe, un programa global diseñado para ayudar al ecosistema de pagos a prepararse para la próxima era de comercio agéntico. El programa se basa en Visa Intelligent Commerce, el portafolio de iniciativas de Visa que habilita experiencias de comercio seguras, impulsadas por inteligencia artificial a escala. Visa Agentic Ready es un programa global creado para ayudar a los bancos emisor...
-

EMCOR Group, Inc. Reports First Quarter 2026 Results

NORWALK, Conn.--(BUSINESS WIRE)--EMCOR Group, Inc. (NYSE: EME) today reported results for the first quarter ended March 31, 2026. First Quarter 2026 Results of Operations For the first quarter of 2026, revenues totaled a quarterly record of $4.63 billion, an increase of 19.7%, compared to $3.87 billion for the first quarter of 2025. On an organic basis, when adjusting for incremental acquisition contribution and the impact of the sale of the Company's United Kingdom operations, first quarter re...
-

Snap-on to Present at Oppenheimer Industrial Growth Conference

KENOSHA, Wis.--(BUSINESS WIRE)--Snap-on is scheduled to present at the Oppenheimer Industrial Growth Conference on Wednesday, May 6, 2026 at 1:30 p.m. ET....
-

Organon Cancels First Quarter Earnings Call

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has canceled its first quarter 2026 earnings conference call previously scheduled for May 7, 2026. The cancellation is the result of the company’s April 26, 2026 announcement that it has entered into an agreement under which Sun Pharmaceutical Industries Limited will acquire Organon. Organon will issue...
-

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for varegacestat, an investigational, oral, once-daily gamma secretase inhibitor (GSI), for the treatment of adults with desmoid tumors. “The varegacestat NDA submission marks an important milestone for Immunome. It r...
-

PHINIA to Participate in Bank of America’s 33rd Annual Industrials, Transportation and Airlines Key Leaders Conference

AUBURN HILLS, Mich.--(BUSINESS WIRE)--PHINIA Inc. (NYSE: PHIN), a leader in premium fuel systems, electrical systems and aftermarket solutions, announced today that it will participate in Bank of America’s 33rd Annual Industrials, Transportation and Airlines Key Leaders Conference on Wednesday, May 13, 2026. Conference participation will be in-person and include a Q&A session to discuss dynamics across the various markets PHINIA serves around the world and the Company’s business. PHINIA’s P...